comparemela.com

Page 12 - ஷில்பா மருத்துவ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nifty50: Ahead of Market: 12 things that will decide stock action on Monday

Even though the 50-scrip Nifty rose for the sixth straight session and closed at lifetime high, it formed an indecisive Doji on the daily chart, signalling weakness and some profit booking ahead.

RDIF, Panacea Biotec join efforts to produce Sputnik V

RDIF, Panacea Biotec join efforts to produce Sputnik V ANI 24 May 2021, 20:37 GMT+10 Moscow [Russia], May 24 (ANI): The Russian Direct Investment Fund (RDIF) and Panacea Biotec, one of the leading pharmaceutical producers in India, on Monday launched the production of the Sputnik V COVID-19 vaccine. According to a press statement, the first batch produced at Panacea Biotec s facilities at Baddi will be shipped to the Gamaleya Center for quality control. Full-scale production of the vaccine is due to start this summer. The company s facilities comply with good manufacturing practice (GMP) standards and are prequalified by World Health Organization (WHO). Launch of production in India in partnership with Panacea Biotec marks an important step in helping the country fight the pandemic. Production of Sputnik V supports efforts of India s authorities to leave behind the acute phase of coronavirus as soon as possible while the vaccine will also be exported at a later stage to help p

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.